Suppressive effect of concurrent administration of metal salts on carcinogenesis by 3'-methyl-4-(dimethylamino)azobenzene, and the effect of these metals on aminoazo dye metabolism during carcinogenesis.
D000818:Animals; D001835:Body Weight; D003300:Copper / Q000494:pharmacology; D005260:Female; D006900:Hydroxylation; D008099:Liver / Q000201:enzymology / Q000378:metabolism / Q000473:pathology; D008113:Liver Neoplasms / Q000139:chemically induced* / Q000378:metabolism / Q000473:pathology; D008345:Manganese / Q000494:pharmacology; D008670:Metals / Q000008:administration & dosage / Q000494:pharmacology*; D008745:Methylation; D009374:Neoplasms, Experimental; D009532:Nickel / Q000494:pharmacology; D011485:Protein Binding; D051381:Rats; D015032:Zinc / Q000494:pharmacology; D004124:p-Dimethylaminoazobenzene / Q000037:antagonists & inhibitors / Q000378:metabolism*
D008670:Metals; D008345:Manganese; D003300:Copper; D009532:Nickel; D004124:p-Dimethylaminoazobenzene; D015032:Zinc